These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10417432)

  • 21. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
    Hillner BE
    Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast.
    Suh WW; Hillner BE; Pierce LJ; Hayman JA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1054-61. PubMed ID: 15752884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence in breast cancer. Analysis with frailty model.
    Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R
    Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer recurrences in elderly patients after lumpectomy.
    Shah S; Doyle K; Lange EM; Shen P; Pennell T; Ferree C; Levine EA; Perrier ND
    Am Surg; 2002 Aug; 68(8):735-9. PubMed ID: 12206612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
    Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
    Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Macro-economic calculation of spending versus micro-economic follow-up of costs of breast cancer].
    Borella L; Paraponaris A
    Rev Epidemiol Sante Publique; 2002 Dec; 50(6):581-92. PubMed ID: 12515928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
    Dardennes R; Lafuma A; Watkins S
    Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
    Nguyen PL; Taghian AG; Katz MS; Niemierko A; Abi Raad RF; Boon WL; Bellon JR; Wong JS; Smith BL; Harris JR
    J Clin Oncol; 2008 May; 26(14):2373-8. PubMed ID: 18413639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic analysis of psychosocial group therapy in women with metastatic breast cancer.
    Lemieux J; Topp A; Chappell H; Ennis M; Goodwin PJ
    Breast Cancer Res Treat; 2006 Nov; 100(2):183-90. PubMed ID: 16773438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local recurrence of stage 1 and 2 breast cancer after skin-sparing mastectomy and immediate breast reconstruction in a 15-year series.
    Meretoja TJ; von Smitten KA; Leidenius MH; Svarvar C; Heikkilä PS; Jahkola TA
    Eur J Surg Oncol; 2007 Dec; 33(10):1142-5. PubMed ID: 17490847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-year follow-up after sentinel node mapping for breast cancer demonstrates better than expected treatment outcomes.
    Fuhrman GM; Gambino J; Bolton JS; Farr G; Jiang X
    Am Surg; 2005 Jul; 71(7):564-9; discussion 569-70. PubMed ID: 16089119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of breast cancer relapse.
    Elder EE; Kennedy CW; Gluch L; Carmalt HL; Janu NC; Joseph MG; Donellan MJ; Molland JG; Gillett DJ
    Eur J Surg Oncol; 2006 Nov; 32(9):922-7. PubMed ID: 16822644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast conserving surgery after primary chemotherapy in locally advanced breast cancer.
    Asoglu O; Muslumanoglu M; Igci A; Ozmen V; Karanlik H; Ayalp K; Bozfakioglu Y; Kecer M; Parlak M
    Acta Chir Belg; 2005 Feb; 105(1):62-8. PubMed ID: 15790205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Impact of the chemotherapy protocols for metastatic breast cancer on the treatment cost and the survival time of 371 patients treated in three hospitals of the Rhone-Alpes region].
    Paviot BT; Bachelot T; Clavreul G; Jacquin JP; Mille D; Rodrigues JM
    Bull Cancer; 2009 Oct; 96(10):929-40. PubMed ID: 19696006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of local and distant disease relapse in patients with breast cancer treated with primary chemotherapy: do patients with a complete pathological response differ from those with residual tumour in the breast?
    Chaturvedi S; McLaren C; Schofield AC; Ogston KN; Sarkar TK; Hutcheon AW; Miller ID; Heys SD
    Breast Cancer Res Treat; 2005 Sep; 93(2):151-8. PubMed ID: 16187235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated patients with breast cancer.
    Wolfort R; de Benedetti A; Nuthalapaty S; Yu H; Chu QD; Li BD
    Surgery; 2006 Aug; 140(2):161-9. PubMed ID: 16904965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
    Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
    Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic breast cancer: we do need primary cost data.
    Bonastre J; Jan P; Barthe Y; Koscielny S
    Breast; 2012 Jun; 21(3):384-8. PubMed ID: 22520336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.